Literature DB >> 33609393

Perioperative management and anaesthetic considerations in pelvic exenterations using Delphi methodology: results from the PelvEx Collaborative.

.   

Abstract

BACKGROUND: The multidisciplinary perioperative and anaesthetic management of patients undergoing pelvic exenteration is essential for good surgical outcomes. No clear guidelines have been established, and there is wide variation in clinical practice internationally. This consensus statement consolidates clinical experience and best practice collectively, and systematically addresses key domains in the perioperative and anaesthetic management.
METHODS: The modified Delphi methodology was used to achieve consensus from the PelvEx Collaborative. The process included one round of online questionnaire involving controlled feedback and structured participant response, two rounds of editing, and one round of web-based voting. It was held from December 2019 to February 2020. Consensus was defined as more than 80 per cent agreement, whereas less than 80 per cent agreement indicated low consensus.
RESULTS: The final consensus document contained 47 voted statements, across six key domains of perioperative and anaesthetic management in pelvic exenteration, comprising preoperative assessment and preparation, anaesthetic considerations, perioperative management, anticipating possible massive haemorrhage, stress response and postoperative critical care, and pain management. Consensus recommendations were developed, based on consensus agreement achieved on 34 statements.
CONCLUSION: The perioperative and anaesthetic management of patients undergoing pelvic exenteration is best accomplished by a dedicated multidisciplinary team with relevant domain expertise in the setting of a specialized tertiary unit. This consensus statement has addressed key domains within the framework of current perioperative and anaesthetic management among patients undergoing pelvic exenteration, with an international perspective, to guide clinical practice, and has outlined areas for future clinical research.
© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33609393      PMCID: PMC7893479          DOI: 10.1093/bjsopen/zraa055

Source DB:  PubMed          Journal:  BJS Open        ISSN: 2474-9842


  64 in total

Review 1.  Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.

Authors:  A Rodgers; N Walker; S Schug; A McKee; H Kehlet; A van Zundert; D Sage; M Futter; G Saville; T Clark; S MacMahon
Journal:  BMJ       Date:  2000-12-16

2.  Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial.

Authors:  John R A Rigg; Konrad Jamrozik; Paul S Myles; Brendan S Silbert; Phillip J Peyton; Richard W Parsons; Karen S Collins
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

3.  Clinical practice guideline for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons (ASCRS) and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).

Authors:  Joseph C Carmichael; Deborah S Keller; Gabriele Baldini; Liliana Bordeianou; Eric Weiss; Lawrence Lee; Marylise Boutros; James McClane; Scott R Steele; Liane S Feldman
Journal:  Surg Endosc       Date:  2017-08-03       Impact factor: 4.584

4.  Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer.

Authors:  Panagiotis A Georgiou; Paris P Tekkis; Vasilis A Constantinides; Uday Patel; Robert D Goldin; Ara W Darzi; R John Nicholls; Gina Brown
Journal:  Eur J Cancer       Date:  2012-10-01       Impact factor: 9.162

5.  Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer.

Authors:  C Miki; J Hiro; E Ojima; Y Inoue; Y Mohri; M Kusunoki
Journal:  Clin Oncol (R Coll Radiol)       Date:  2006-02       Impact factor: 4.126

6.  Minimally invasive surgery techniques in pelvic exenteration: a systematic and meta-analysis review.

Authors: 
Journal:  Surg Endosc       Date:  2018-07-17       Impact factor: 4.584

7.  The choice of anaesthetic--sevoflurane or propofol--and outcome from cancer surgery: a retrospective analysis.

Authors:  Mats Enlund; Anders Berglund; Kalle Andreasson; Catharina Cicek; Anna Enlund; Leif Bergkvist
Journal:  Ups J Med Sci       Date:  2014-05-26       Impact factor: 2.384

Review 8.  Intravascular volume therapy in adults: Guidelines from the Association of the Scientific Medical Societies in Germany.

Authors:  Gernot Marx; Achim W Schindler; Christoph Mosch; Joerg Albers; Michael Bauer; Irmela Gnass; Carsten Hobohm; Uwe Janssens; Stefan Kluge; Peter Kranke; Tobias Maurer; Waltraut Merz; Edmund Neugebauer; Michael Quintel; Norbert Senninger; Hans-Joachim Trampisch; Christian Waydhas; Rene Wildenauer; Kai Zacharowski; Michaela Eikermann
Journal:  Eur J Anaesthesiol       Date:  2016-07       Impact factor: 4.330

9.  Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery.

Authors:  Anna Wrzosek; Joanna Jakowicka-Wordliczek; Renata Zajaczkowska; Wojciech T Serednicki; Milosz Jankowski; Malgorzata M Bala; Mateusz J Swierz; Maciej Polak; Jerzy Wordliczek
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12

10.  Perioperative Blood Transfusion is Associated with Postoperative Systemic Inflammatory Response and Poorer Outcomes Following Surgery for Colorectal Cancer.

Authors:  Stephen T McSorley; Alexander Tham; Ross D Dolan; Colin W Steele; Jason Ramsingh; Campbell Roxburgh; Paul G Horgan; Donald C McMillan
Journal:  Ann Surg Oncol       Date:  2019-10-29       Impact factor: 5.344

View more
  1 in total

Review 1.  Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative.

Authors: 
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.